STOCK TITAN

AMERICAN HEALTHCARE REIT INC Form 4 Filings

AHR NYSE

Every Form 4 that AMERICAN HEALTHCARE REIT INC (AHR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AHR filings page.

Rhea-AI Summary

American Healthcare REIT, Inc. (AHR) officer Mark E. Foster, EVP, GC & Secretary, reported selling 2,000 shares of common stock on 2026-09-01 at $55.39 per share in an open-market or private transaction. The sale was executed under a Rule 10b5-1 trading plan adopted on 2025-12-19 and made pursuant to an exception to a lock-up agreement related to the company’s offering that closed on 2026-08-12. Following this sale, Foster directly held 51,617 shares, which includes 622 shares acquired through the company’s Employee Stock Purchase Plan.

Rhea-AI Summary

American Healthcare REIT, Inc. director Danny Prosky received a grant of 2,594 shares of restricted common stock on July 21, 2026 in connection with his transition to a non-employee director; these shares vest on June 24, 2027.

This Form 4/A amends a prior Form 4 to include 622 shares acquired under the Employee Stock Purchase Plan, bringing Prosky's directly held common stock to 313,592 shares following the award.

Rhea-AI Summary

American Healthcare REIT, Inc. granted Chief Executive Officer Jeffrey T. Hanson 35,981 time-based restricted stock units on July 21, 2026 in connection with his appointment. Each RSU converts into one share of common stock and will vest in three equal annual installments on July 21, 2027, 2028 and 2029, subject to continuous service. Following this award, Hanson directly holds 35,981 RSUs.

Rhea-AI Summary

Willhite Gabriel M reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. reported an equity compensation grant to President & COO Gabriel M. Willhite. On July 21, 2026 he received 6,038 restricted stock units, each convertible into one share of common stock. The RSUs will vest in three equal annual installments on March 10, 2027, 2028 and 2029, subject to continuous service, leaving him with 6,038 RSUs directly held after this award.

Rhea-AI Summary

American Healthcare REIT director Danny Prosky reported equity compensation changes tied to his transition to a non-employee director. On July 21, 2026, time-based RSUs converted into common stock, and the company repurchased or withheld shares at $56.66 per share to satisfy related tax obligations. Prosky also received 2,594 shares of restricted common stock vesting on June 24, 2027, and 201,403 shares of common stock are held indirectly through a family trust for which Danny and Zohar Prosky serve as trustees.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Financial Officer Brian Peay reported insider transactions in the company’s common stock. On June 26, 2026, he completed an open-market sale of 25,000 shares at a weighted average price of $50.6961 per share, executed in multiple trades between $50.44 and $50.94. After this sale, he directly holds 152,700 common shares. Separately, an indirect holding entry shows 807 common shares held through the Brian and Kristen Peay 2007 Trust, where Brian and Kristen Peay are trustees.

Rhea-AI Summary

American Healthcare REIT, Inc. executive Mark E. Foster, EVP, GC & Secretary, reported an open-market sale of 2,500 shares of Common Stock at $48.58 per share. After this transaction, he directly holds 52,995 shares, so the sale represents a small portion of his reported stake.

Rhea-AI Summary

Richardson Valerie reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Valerie Richardson received an equity award of 2,594 shares of common stock as compensation upon her re-election to the board on June 24, 2026. The award is in the form of restricted common stock that will vest on June 24, 2027. After this grant, she directly holds a total of 20,656 common shares.

Rhea-AI Summary

O'Quinn Marvin R reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Marvin R. O'Quinn received an equity grant of company stock. He was granted 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest in full on June 24, 2027. Following this award, he directly holds 20,656 shares of common stock. The grant was a compensation-related award at no cash cost to him, rather than an open-market purchase.

Rhea-AI Summary

Smith Wilbur H III reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Wilbur H. Smith III received a grant of 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest in full on June 24, 2027. Following this equity award, he holds 35,013 shares of common stock directly.

Rhea-AI Summary

Streiff Mathieu B. reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Mathieu B. Streiff reported an equity compensation grant. Upon his re-election to the board on June 24, 2026, he received 2,594 shares of restricted common stock, which vest on June 24, 2027. Following this award, he holds 34,971 shares of common stock directly and 157,402 shares indirectly through The Streiff Family Trust UA DTD 03/26/2013.

Rhea-AI Summary

Flornes Brian J. reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Brian J. Flornes received a grant of 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest on June 24, 2027, and bring his direct holdings to 33,020 common shares.

Rhea-AI Summary

Hurley Dianne reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Dianne Hurley received a grant of 2,594 shares of restricted common stock on June 24, 2026, in connection with her re-election to the board. The award was made at no cash cost to her and increases her direct holdings to 34,037 shares.

The restricted shares are scheduled to vest on June 24, 2027, meaning they become fully owned by her on that date if vesting conditions are met. This filing reflects routine director equity compensation rather than an open-market purchase or sale.

Rhea-AI Summary

ESTES SCOTT A reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Scott A. Estes reported an equity compensation grant rather than an open-market trade. Upon his re-election to the board, he received 2,594 shares of restricted common stock on June 24, 2026, at no cash cost per share.

The filing shows these restricted shares will vest on June 24, 2027, meaning they fully belong to him on that date if conditions are met. After this award, Estes directly holds 21,489 shares of common stock, giving investors a clearer view of his current equity stake.

Rhea-AI Summary

American Healthcare REIT, Inc. executive vice president, general counsel and secretary Mark E. Foster sold 2,000 shares of common stock in an open-market transaction at $48.32 per share. After this sale, he directly holds 55,495 shares of the company’s stock.

The sale occurred on June 1, 2026 under a pre-established Rule 10b5-1 trading plan adopted on December 19, 2025. The transaction was also completed under an exception to a lock-up agreement tied to the company’s underwritten common stock offering that closed on May 22, 2026.

Rhea-AI Summary

American Healthcare REIT EVP, GC & Secretary Mark E. Foster exercised equity awards and had shares withheld for taxes. On April 6, 2026, 2,986 restricted stock units converted into 2,986 shares of common stock. Of these, 1,612 shares were withheld at $48.09 per share to cover tax obligations, leaving Foster with 57,495 common shares held directly. These RSUs were part of an 8,957-unit time-based award granted on April 3, 2023 that vests in three equal annual installments on April 3, 2024, 2025 and 2026, subject to continued employment.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Investment Officer Stefan K.L. Oh exercised restricted stock units into common shares and had shares withheld for taxes. On April 6, 2026, 3,185 RSUs converted into 3,185 shares of common stock. Of these, 1,621 shares were withheld by the company at $48.09 per share to cover tax obligations tied to time-based RSUs that vested on April 3, 2026. Following these compensation-related transactions, Oh directly holds 96,994 shares of common stock.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Operating Officer Gabriel M. Willhite exercised restricted stock units that converted into 6,768 shares of common stock on April 6, 2026. To cover related tax obligations from time-based RSUs that vested on April 3, 2026, 3,654 shares were withheld by the company at a price of $48.09 per share. After these routine compensation-related transactions, Willhite directly holds 148,165 shares of common stock. These RSUs were part of a 20,303-unit award granted on April 3, 2023 that vests in three equal annual installments, subject to continued employment.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Financial Officer Brian Peay reported routine equity compensation activity involving restricted stock units. On April 6, 2026, 6,768 RSUs converted into the same number of shares of common stock. These RSUs were part of a 20,303-unit time-based grant awarded on April 3, 2023 that vests in three equal annual installments.

To cover associated tax obligations from the April 3, 2026 vesting, the company withheld 3,654 shares at a price of $48.09 per share, rather than selling them in the open market. After these transactions, Peay holds 177,700 shares of common stock directly and 807 shares indirectly through the Brian and Kristen Peay 2007 Trust.

Rhea-AI Summary

American Healthcare REIT, Inc. director Danny Prosky reported routine equity compensation activity. On April 6, 2026, 15,924 restricted stock units converted into an equal number of common shares as part of a previously awarded time-based RSU grant that vests in three annual installments.

To cover tax obligations from the April 3, 2026 vesting, 8,596 common shares were withheld by the company at $48.09 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, Prosky directly holds 346,469 common shares and indirectly holds 201,403 shares through the Danny & Zohar Prosky Family Rev Trust.

Rhea-AI Summary

American Healthcare REIT, Inc. granted Interim CEO and President Jeffrey T. Hanson 42,756 time-based restricted stock units on March 26, 2026. Each RSU converts into one share of common stock, giving him 42,756 common shares subject to vesting conditions.

The RSUs vest on the earlier of March 15, 2027, or within 30 days after his service ends as Interim CEO. If his interim role ends before December 31, 2026, he receives a pro-rated portion of the grant’s value based on time served in 2026.

Rhea-AI Summary

American Healthcare REIT EVP, GC & Secretary Mark E. Foster reported compensation-related stock activity and a small share sale. On March 25, 2026, 11,108 restricted stock units converted into the same number of common shares, while 5,652 shares were withheld to cover tax obligations.

He also sold 2,000 common shares at $48.55 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these moves, Foster directly holds 56,121 shares of common stock and received a new grant of 6,510 time-based RSUs that will vest in equal parts from 2027 through 2029.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Investment Officer Stefan K.L. Oh reported routine equity compensation activity involving restricted stock units and common stock. On March 25, 2026, 9,151 and 5,086 restricted stock units converted into the same number of common shares as scheduled vesting events.

The company withheld 4,657 and 2,588 common shares, valued at $48.25 per share, to cover Mr. Oh’s tax obligations tied to these vestings, which are not open‑market sales. He also received a new grant of 9,510 time‑based restricted stock units. Following these transactions, he holds 95,430 common shares directly.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Operating Officer Gabriel M. Willhite reported routine equity compensation activity. On March 25, 2026, two blocks of time-based restricted stock units converted into a total of 15,205 shares of common stock as they vested. To cover associated tax obligations, 4,948 and 2,790 common shares were withheld by the company at a price of $48.25 per share. Following these transactions, Willhite directly held 145,051 shares of common stock. He also received a new grant of 10,317 time-based RSUs that will vest in equal installments on March 10, 2027, 2028 and 2029, subject to continued employment.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Financial Officer Brian Peay reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On March 25, 2026, 21,922 RSUs converted into the same number of common shares, reflecting previously granted time-based awards that vested on that date.

To cover tax obligations from these vestings, 11,155 common shares were withheld by the company at $48.25 per share, so no open-market sale occurred. Peay also received a new grant of 15,114 time-based RSUs, which will vest in three equal installments on March 10, 2027, 2028 and 2029, subject to continued employment.

After these transactions, he directly holds 174,586 shares of common stock and has an additional 807 shares held indirectly through the Brian and Kristen Peay 2007 Trust. The filing shows compensation-related equity vesting and grants, rather than discretionary stock purchases or sales.

Rhea-AI Summary

American Healthcare REIT director Danny Prosky reported routine equity compensation activity. On March 25, 2026, 51,797 restricted stock units converted 1:1 into common shares at an exercise price of $0.00 per share. The company withheld 26,356 shares at $48.25 per share to cover tax obligations tied to these vestings.

After these transactions, Prosky directly held 339,141 shares of common stock and indirectly held 201,403 shares through the Danny & Zohar Prosky Family Rev Trust UA DTD 08/16/2011. Footnotes show prior time-based RSU awards of 92,656 units granted on March 25, 2024 and 62,737 units granted on March 25, 2025, each vesting ratably over three annual dates.

Rhea-AI Summary

American Healthcare REIT EVP, GC & Secretary Mark E. Foster had performance-based restricted stock units vest on March 12, 2026, converting into 5,972 shares of common stock. To cover related tax obligations, 3,222 shares were withheld by the company at $52.80 per share, leaving him with 52,665 common shares held directly.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Investment Officer Stefan K.L. Oh received a performance-based restricted stock unit (PRSU) award that vested into 6,370 shares of common stock on March 12, 2026. Each unit converted into one share of common stock under the company’s incentive plan.

To cover related tax obligations, 3,437 shares of common stock were withheld by the company at a price of $52.80 per share. After these compensation-related transactions and tax withholding, Oh directly holds 88,438 shares of common stock, reflecting a net increase in his equity stake.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Operating Officer Gabriel M. Willhite reported compensation-related equity activity. On March 12, 2026, 13,534 performance-based restricted stock units vested and converted into 13,534 shares of common stock, following performance goals confirmed as met. These PRSUs were originally granted without cash consideration on April 3, 2023 under the company’s Second Amended and Restated 2015 Incentive Plan. To cover associated tax obligations, 7,302 common shares were withheld by the company at $52.8000 per share, leaving Willhite with 137,584 common shares held directly after the transactions.

Rhea-AI Summary

American Healthcare REIT, Inc. Chief Financial Officer Brian Peay reported equity compensation activity tied to performance-based restricted stock units. On March 12, 2026, 13,534 restricted stock units, originally granted on April 3, 2023, vested after their performance goals were confirmed as met and converted 1-for-1 into 13,534 shares of common stock. To cover tax obligations from this vesting, 7,302 common shares were withheld by the company at a value of $52.80 per share, a non-market disposition that functions as a tax payment rather than an open-market sale. Following these transactions, Peay holds 163,819 shares of common stock directly and 807 shares indirectly through the Brian and Kristen Peay 2007 Trust.

Rhea-AI Summary

American Healthcare REIT, Inc. director Danny Prosky reported vesting and settlement of performance-based restricted stock units. On March 12, 2026, 31,846 restricted stock units converted into an equal number of common shares at no cash cost, reflecting the achievement of previously set performance goals.

To cover related tax obligations, the company withheld 17,181 common shares valued at $52.80 per share, a non–open-market disposition. After these transactions, Prosky holds 313,700 shares of common stock directly and 201,403 shares indirectly through the Danny & Zohar Prosky Family Revocable Trust.

Rhea-AI Summary

American Healthcare REIT, Inc. executive Mark E. Foster reported a tax-related share disposition. On February 9, 2026, the company repurchased 7,685 shares of common stock at $48.77 per share from Foster to cover his tax obligations from vesting restricted stock. Following this tax-withholding transaction, Foster directly beneficially owns 49,915 shares of American Healthcare REIT common stock.

Rhea-AI Summary

Oh Stefan K.L. reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 10,166 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 85,505 shares.

Rhea-AI Summary

Willhite Gabriel M reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 17,133 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 131,352 shares.

Rhea-AI Summary

PEAY BRIAN reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 20,109 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 157,587 shares.

Rhea-AI Summary

Prosky Danny reported disposition transactions in a Form 4 filing for AHR. The filing lists transactions totaling 29,992 shares at a weighted average price of $48.77 per share. Following the reported transactions, holdings were 299,035 shares.

Rhea-AI Summary

American Healthcare REIT, Inc. director Jeffrey T. Hanson filed a Form 4 reporting sales of company common stock and his indirect holdings. On 12/22/2025, a trust associated with him sold 35,570 shares of common stock at a weighted average price of $48.3753 per share. On 12/23/2025, the same trust sold an additional 19,208 shares at a weighted average price of $48.4012 per share, after which the trust no longer held shares.

Hanson also reports indirect holdings through several retirement and pension accounts, including IRAs, 401(k) plans, and a defined benefit pension plan. In addition, he reports 1,268,643 OP Units in American Healthcare REIT Holdings, LP held by AHI Group Holdings, LLC, which he owns and controls with two other executives. He states that he is reporting these OP Units for transparency and continues to disclaim beneficial ownership beyond his pecuniary interest.

Rhea-AI Summary

American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).

The sale was executed in multiple trades between $49.35 and $49.37. Following the transaction, Foster beneficially owns 57,600 shares directly.

Rhea-AI Summary

American Healthcare REIT (AHR) director Jeffrey T. Hanson reported an open‑market sale of 20,010 shares of common stock on 11/10/2025 at a weighted average price of $49.6804 (Transaction Code S). Following the sale, he held 21,798 shares directly.

He also reports indirect holdings including 54,778 shares by the Hanson Family Trust, 5,552 by April L. Hanson IRA, 2,515 by Crescentridge 401(k), 16,720 by a Defined Benefit Pension Plan, 729 by spouse’s 401(k), and 4,869 by JTH Holdings LLC DBPP. Additionally, 1,268,643 OP Units are held by AHI Group Holdings, LLC; Mr. Hanson disclaims beneficial ownership except to his pecuniary interest.